Cardiovascular Toxicities of Immune Therapies for Cancer – A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology

Tocchetti, CG; Farmakis, D; Koop, Y; Andres, MS; Couch, LS; Formisano, L; Ciardiello, F; Pane, F; Au, L; Emmerich, M; Plummer, C; Gulati, G; Ramalingam, S; Cardinale, D; Brezden-Masley, C; Iakobishvili, Z; Thavendiranathan, P; Santoro, C; Bergler-Klein, J; Keramida, K; de Boer, RA; Maack, C; Lutgens, E; Rassaf, T; Fradley, MG; Moslehi, J; Yang, EH; De Keulenaer, G; Ameri, P; Bax, J; Neilan, TG; Herrmann, J; Mbakwem, AC; Mirabel, M; Skouri, H; Hirsch, E; Cohen-Solal, A; Sverdlov, AL; van der Meer, P; Asteggiano, R; Barac, A; Ky, B; Lenihan, D; Dent, S; Seferovic, P; Coats, AJS; Metra, M; Rosano, G; Suter, T; Lopez-Fernandez, T; Lyon, AR

doi:10.1002/ejhf.3340

Cardio-oncology & other

Cardiovascular Toxicities of Immune Therapies for Cancer – A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology

Eur J Heart FailPublished 1 Aug 2024Scientific statement

Read the original article ↗PubMed

Cite

Scope

As issued by the authors

CV toxicities of immune therapies for cancer (ICI, CAR-T, natural killer (NK) and TIL therapies): pathophysiology, epidemiology, diagnosis and management; gaps in the literature and future research

Reference

Issued by: Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology
Document: Scientific statement

Authors: Tocchetti CG, Farmakis D, Koop Y, Andres MS, Couch LS, Formisano L, et al.
All 51 authors
Tocchetti CG, Farmakis D, Koop Y, Andres MS, Couch LS, Formisano L, Ciardiello F, Pane F, Au L, Emmerich M, Plummer C, Gulati G, Ramalingam S, Cardinale D, Brezden-Masley C, Iakobishvili Z, Thavendiranathan P, Santoro C, Bergler-Klein J, Keramida K, de Boer RA, Maack C, Lutgens E, Rassaf T, Fradley MG, Moslehi J, Yang EH, De Keulenaer G, Ameri P, Bax J, Neilan TG, Herrmann J, Mbakwem AC, Mirabel M, Skouri H, Hirsch E, Cohen-Solal A, Sverdlov AL, van der Meer P, Asteggiano R, Barac A, Ky B, Lenihan D, Dent S, Seferovic P, Coats AJS, Metra M, Rosano G, Suter T, Lopez-Fernandez T, Lyon AR
Journal: European Journal of Heart Failure
Published: 1 Aug 2024
DOI: 10.1002/ejhf.3340
PubMed: 39087551

Topic: Cardio-oncology & other

Original publication

Cardiovascular Toxicities of Immune Therapies for Cancer – A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology. Eur J Heart Fail. Published 1 August 2024. doi:10.1002/ejhf.3340

Read the original article ↗

Composed by AI from the published abstract and checked against it. How Briefs are made →